133 related articles for article (PubMed ID: 30243186)
1. The survival effect of valproic acid in glioblastoma and its current trend: a systematic review and meta-analysis.
Lu VM; Texakalidis P; McDonald KL; Mekary RA; Smith TR
Clin Neurol Neurosurg; 2018 Nov; 174():149-155. PubMed ID: 30243186
[TBL] [Abstract][Full Text] [Related]
2. Effect of valproic acid on seizure control and on survival in patients with glioblastoma multiforme.
Kerkhof M; Dielemans JC; van Breemen MS; Zwinkels H; Walchenbach R; Taphoorn MJ; Vecht CJ
Neuro Oncol; 2013 Jul; 15(7):961-7. PubMed ID: 23680820
[TBL] [Abstract][Full Text] [Related]
3. Valproic acid, compared to other antiepileptic drugs, is associated with improved overall and progression-free survival in glioblastoma but worse outcome in grade II/III gliomas treated with temozolomide.
Redjal N; Reinshagen C; Le A; Walcott BP; McDonnell E; Dietrich J; Nahed BV
J Neurooncol; 2016 May; 127(3):505-14. PubMed ID: 26830093
[TBL] [Abstract][Full Text] [Related]
4. Effect of valproic acid on the outcome of glioblastoma multiforme.
Tsai HC; Wei KC; Tsai CN; Huang YC; Chen PY; Chen SM; Lu YJ; Lee ST
Br J Neurosurg; 2012 Jun; 26(3):347-54. PubMed ID: 22168970
[TBL] [Abstract][Full Text] [Related]
5. Does Valproic Acid or Levetiracetam Improve Survival in Glioblastoma? A Pooled Analysis of Prospective Clinical Trials in Newly Diagnosed Glioblastoma.
Happold C; Gorlia T; Chinot O; Gilbert MR; Nabors LB; Wick W; Pugh SL; Hegi M; Cloughesy T; Roth P; Reardon DA; Perry JR; Mehta MP; Stupp R; Weller M
J Clin Oncol; 2016 Mar; 34(7):731-9. PubMed ID: 26786929
[TBL] [Abstract][Full Text] [Related]
6. Impact of particular antiepileptic drugs on the survival of patients with glioblastoma multiforme.
Guthrie GD; Eljamel S
J Neurosurg; 2013 Apr; 118(4):859-65. PubMed ID: 23176328
[TBL] [Abstract][Full Text] [Related]
7. Survival analysis for valproic acid use in adult glioblastoma multiforme: a meta-analysis of individual patient data and a systematic review.
Yuan Y; Xiang W; Qing M; Yanhui L; Jiewen L; Yunhe M
Seizure; 2014 Nov; 23(10):830-5. PubMed ID: 25066904
[TBL] [Abstract][Full Text] [Related]
8. The Survival Effect of Repeat Surgery at Glioblastoma Recurrence and its Trend: A Systematic Review and Meta-Analysis.
Lu VM; Jue TR; McDonald KL; Rovin RA
World Neurosurg; 2018 Jul; 115():453-459.e3. PubMed ID: 29654958
[TBL] [Abstract][Full Text] [Related]
9. Roles of Valproic Acid in Improving Radiation Therapy for Glioblastoma: a Review of Literature Focusing on Clinical Evidence.
Ochiai S; Nomoto Y; Yamashita Y; Watanabe Y; Toyomasu Y; Kawamura T; Takada A; Ii N; Kobayashi S; Sakuma H
Asian Pac J Cancer Prev; 2016; 17(2):463-6. PubMed ID: 26925628
[TBL] [Abstract][Full Text] [Related]
10. The impact of hyperglycemia on survival in glioblastoma: A systematic review and meta-analysis.
Lu VM; Goyal A; Vaughan LS; McDonald KL
Clin Neurol Neurosurg; 2018 Jul; 170():165-169. PubMed ID: 29803727
[TBL] [Abstract][Full Text] [Related]
11. A Phase 2 Study of Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid for Patients With Glioblastoma.
Krauze AV; Myrehaug SD; Chang MG; Holdford DJ; Smith S; Shih J; Tofilon PJ; Fine HA; Camphausen K
Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):986-992. PubMed ID: 26194676
[TBL] [Abstract][Full Text] [Related]
12. Revisiting Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid for Patients with Glioblastoma-Proteomic Alteration and Comparison Analysis with the Standard-of-Care Chemoirradiation.
Krauze AV; Zhao Y; Li MC; Shih J; Jiang W; Tasci E; Cooley Zgela T; Sproull M; Mackey M; Shankavaram U; Tofilon P; Camphausen K
Biomolecules; 2023 Oct; 13(10):. PubMed ID: 37892181
[TBL] [Abstract][Full Text] [Related]
13. Antiangiogenic therapy for high-grade glioma.
Khasraw M; Ameratunga MS; Grant R; Wheeler H; Pavlakis N
Cochrane Database Syst Rev; 2014 Sep; (9):CD008218. PubMed ID: 25242542
[TBL] [Abstract][Full Text] [Related]
14. Prognostic relevance of epilepsy at presentation in glioblastoma patients.
Berendsen S; Varkila M; Kroonen J; Seute T; Snijders TJ; Kauw F; Spliet WG; Willems M; Poulet C; Broekman ML; Bours V; Robe PA
Neuro Oncol; 2016 May; 18(5):700-6. PubMed ID: 26420896
[TBL] [Abstract][Full Text] [Related]
15. Anti-epileptic drug use during adjuvant chemo-radiotherapy is associated with poorer survival in patients with glioblastoma: A nationwide population-based cohort study.
Lee PY; Wei YT; Chao KC; Chu CN; Chung WH; Wang TH
J Cancer Res Ther; 2024 Apr; 20(2):555-562. PubMed ID: 38687925
[TBL] [Abstract][Full Text] [Related]
16. Quantifying the prognostic significance in glioblastoma of seizure history at initial presentation: A systematic review and meta-analysis.
Lu VM; Jue TR; Phan K; McDonald KL
Clin Neurol Neurosurg; 2018 Jan; 164():75-80. PubMed ID: 29202377
[TBL] [Abstract][Full Text] [Related]
17. Cellular Effects of the Antiepileptic Drug Valproic Acid in Glioblastoma.
Eckert M; Klumpp L; Huber SM
Cell Physiol Biochem; 2017; 44(4):1591-1605. PubMed ID: 29212069
[TBL] [Abstract][Full Text] [Related]
18. The effect of valproic acid in combination with irradiation and temozolomide on primary human glioblastoma cells.
Hosein AN; Lim YC; Day B; Stringer B; Rose S; Head R; Cosgrove L; Sminia P; Fay M; Martin JH
J Neurooncol; 2015 Apr; 122(2):263-71. PubMed ID: 25648357
[TBL] [Abstract][Full Text] [Related]
19. Valproic acid inhibits glioblastoma multiforme cell growth via paraoxonase 2 expression.
Tseng JH; Chen CY; Chen PC; Hsiao SH; Fan CC; Liang YC; Chen CP
Oncotarget; 2017 Feb; 8(9):14666-14679. PubMed ID: 28108734
[TBL] [Abstract][Full Text] [Related]
20. The effect of levetiracetam treatment on survival in patients with glioblastoma: a systematic review and meta-analysis.
Chen JS; Clarke R; Haddad AF; Wang EJ; Lacroix M; Sarkar IN; Zand R; Chen ES; Toms SA
J Neurooncol; 2022 Jan; 156(2):257-267. PubMed ID: 34982371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
